Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |